Christiane Querfeld, Julia Scarisbrick, Oleg Akilov, Martine Bagot, Raul Cordoba, Richard Cowan, Alejandro Martıń Garcıá-Sancho, Larisa J. Geskin, Auris O. Huen, Stephen Morris, Pablo L. Ortiz-Romero, Lauren C. Pinter-Brown, Ramon M. Pujol, Pietro Quaglino, Nakhle S. Saba, Yi Liu, Henry Zhao, Payal Arora, Youn H. Kim
{"title":"Mogamulizumab用于蕈样真菌病/ ssamzary综合征患者:MOGA-2MG-Q4W 2期,开放标签,多中心,单组研究,评估4周给药计划的转化数据结果","authors":"Christiane Querfeld, Julia Scarisbrick, Oleg Akilov, Martine Bagot, Raul Cordoba, Richard Cowan, Alejandro Martıń Garcıá-Sancho, Larisa J. Geskin, Auris O. Huen, Stephen Morris, Pablo L. Ortiz-Romero, Lauren C. Pinter-Brown, Ramon M. Pujol, Pietro Quaglino, Nakhle S. Saba, Yi Liu, Henry Zhao, Payal Arora, Youn H. Kim","doi":"10.1016/j.ejca.2025.115851","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":11980,"journal":{"name":"European Journal of Cancer","volume":"229 ","pages":""},"PeriodicalIF":7.1000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Mogamulizumab in patients with mycosis fungoides/Sézary syndrome: Translational data results from the MOGA-2MG-Q4W Phase 2, open-label, multicenter, single-arm study assessing a 4-weekly dosing schedule\",\"authors\":\"Christiane Querfeld, Julia Scarisbrick, Oleg Akilov, Martine Bagot, Raul Cordoba, Richard Cowan, Alejandro Martıń Garcıá-Sancho, Larisa J. Geskin, Auris O. Huen, Stephen Morris, Pablo L. Ortiz-Romero, Lauren C. Pinter-Brown, Ramon M. Pujol, Pietro Quaglino, Nakhle S. Saba, Yi Liu, Henry Zhao, Payal Arora, Youn H. Kim\",\"doi\":\"10.1016/j.ejca.2025.115851\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":11980,\"journal\":{\"name\":\"European Journal of Cancer\",\"volume\":\"229 \",\"pages\":\"\"},\"PeriodicalIF\":7.1000,\"publicationDate\":\"2025-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Cancer\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S095980492500680X\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Cancer","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S095980492500680X","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
Mogamulizumab in patients with mycosis fungoides/Sézary syndrome: Translational data results from the MOGA-2MG-Q4W Phase 2, open-label, multicenter, single-arm study assessing a 4-weekly dosing schedule
期刊介绍:
The European Journal of Cancer (EJC) serves as a comprehensive platform integrating preclinical, digital, translational, and clinical research across the spectrum of cancer. From epidemiology, carcinogenesis, and biology to groundbreaking innovations in cancer treatment and patient care, the journal covers a wide array of topics. We publish original research, reviews, previews, editorial comments, and correspondence, fostering dialogue and advancement in the fight against cancer. Join us in our mission to drive progress and improve outcomes in cancer research and patient care.